Transplantation of autologous bone marrow pre-loaded
Animals
Bone Marrow
Bortezomib
/ pharmacology
Cyclophosphamide
Hematopoietic Stem Cell Transplantation
/ methods
Humans
Immune Checkpoint Inhibitors
Mice
Mice, Inbred C57BL
Multiple Myeloma
/ therapy
Myxoma virus
Oncolytic Virotherapy
/ methods
Oncolytic Viruses
Programmed Cell Death 1 Receptor
Transplantation, Autologous
autologous transplantation
combination therapy
multiple myeloma
myxoma virus
oncolytic virus
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
12
2021
accepted:
14
02
2022
entrez:
7
3
2022
pubmed:
8
3
2022
medline:
8
3
2022
Statut:
epublish
Résumé
Multiple myeloma (MM) is a hematological malignancy of plasma cells that remains incurable despite significant progress with myeloablative regimens and autologous stem cell transplantation for eligible patients and, more recently with T cell redirected immunotherapy. Recently, we reported that
Identifiants
pubmed: 35251496
doi: 10.18632/oncotarget.28205
pii: 28205
pmc: PMC8893797
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Programmed Cell Death 1 Receptor
0
Bortezomib
69G8BD63PP
Cyclophosphamide
8N3DW7272P
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
490-504Subventions
Organisme : NCI NIH HHS
ID : P50 CA186781
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI080607
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234181
Pays : United States
Informations de copyright
Copyright: © 2022 Villa et al.
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST Grant McFadden (GM) is co-founder and equity holder of OncoMyx Therapeutics. M.M.R. is a consultant for OncoMyx Therapeutics.
Références
Blood. 2012 Jul 12;120(2):376-85
pubmed: 22451422
Adv Virol. 2012;2012:805629
pubmed: 22400027
Mol Ther Oncolytics. 2021 Aug 06;22:539-554
pubmed: 34553039
Mol Ther Oncolytics. 2020 Jun 24;18:171-188
pubmed: 32695875
Turk J Haematol. 2019 Jan 02;36(2):72-80
pubmed: 30600678
Cancer Res. 2005 Dec 15;65(24):11255-8
pubmed: 16357128
Cancers (Basel). 2021 Oct 29;13(21):
pubmed: 34771615
Nat Biotechnol. 2012 Jul 10;30(7):658-70
pubmed: 22781695
Bonekey Rep. 2012 Aug 01;1:135
pubmed: 23951515
Hematology. 2015 Jan;20(1):58-9
pubmed: 25602931
Front Immunol. 2018 Nov 16;9:2431
pubmed: 30505301
Mol Ther Oncolytics. 2019 Apr 25;13:93-106
pubmed: 31080879
Cancer Res. 2005 Nov 1;65(21):9982-9990
pubmed: 16267023
Cancer Cell. 2008 Feb;13(2):167-80
pubmed: 18242516
Blood. 2005 Apr 1;105(7):2862-8
pubmed: 15591121
Oncotarget. 2018 Apr 13;9(28):20119-20133
pubmed: 29732008
Viruses. 2010 Jan;2(1):78-106
pubmed: 20543907
Leukemia. 2020 Dec;34(12):3310-3322
pubmed: 32327728
Cold Spring Harb Perspect Med. 2018 Aug 1;8(8):
pubmed: 29229668
Blood Adv. 2019 Mar 12;3(5):797-812
pubmed: 30850386
Cancer Cell. 2021 Feb 8;39(2):193-208.e10
pubmed: 33357452
J Clin Oncol. 2014 Oct 1;32(28):3103-10
pubmed: 25113756
PLoS One. 2012;7(12):e51892
pubmed: 23284805
Cell Death Discov. 2021 Feb 19;7(1):36
pubmed: 33608503
Science. 2000 Sep 1;289(5484):1504-8
pubmed: 10968780
Biomed Pharmacother. 2020 May;125:110030
pubmed: 32187960
Blood. 2003 Jul 1;102(1):377-87
pubmed: 12637331
Mol Ther Oncolytics. 2016 Dec 14;4:31-40
pubmed: 28345022
Anticancer Res. 2015 Apr;35(4):2165-8
pubmed: 25862873
Sci Rep. 2019 Oct 2;9(1):14189
pubmed: 31578352
Hematol Oncol. 2019 Jun;37 Suppl 1:62-65
pubmed: 31187526
Cancer Immunol Immunother. 2007 May;56(5):641-8
pubmed: 16960692
Cancers (Basel). 2018 Jun 14;10(6):
pubmed: 29903988
Cancers (Basel). 2021 May 18;13(10):
pubmed: 34070213
J Virol. 2007 Jan;81(1):106-14
pubmed: 17065210
Eur J Immunol. 2004 Feb;34(2):336-44
pubmed: 14768038
Oncogene. 2001 Jul 27;20(33):4519-27
pubmed: 11494147
Gene Ther. 2001 Jan;8(2):89-98
pubmed: 11313778
Nat Med. 2016 Dec;22(12):1411-1420
pubmed: 27841872
Blood Cancer Discov. 2021 Jul;2(4):354-369
pubmed: 34258584
Arch Biochem Biophys. 2008 May 15;473(2):147-60
pubmed: 18237538
Mayo Clin Proc. 2016 Jan;91(1):101-19
pubmed: 26763514